All In Biotech

Free tool

FAERS Monitor: Vimpat

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 022255 or its brand name (Vimpat, Lacosamide). Reports on generic versions are filed under their own applications.

Reports

37,919

Serious

29,864

79% of reports

Hospitalization

13,001

Death reported

3,199

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • seizure6,979
  • drug ineffective4,243
  • off label use4,083
  • dizziness1,693
  • somnolence1,521
  • fatigue1,474
  • epilepsy1,466
  • fall1,436
  • overdose1,308
  • status epilepticus1,291
  • generalised tonic-clonic seizure1,209
  • death1,095
  • headache1,082
  • drug interaction1,026
  • nausea967

Reports by year received

View as table
YearReports
20071
20082
2009332
2010611
2011886
2012875
2013929
2014956
20151,994
20161,342
20171,652
20182,469
20193,766
20202,936
20213,545
20223,208
20233,140
20243,497
20253,315
20262,463

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,016,240 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
status epilepticusSignal1,29171.567.579,442
generalised tonic-clonic seizureSignal1,20943.641.246,687
seizureSignal6,97935.634.8221,729
epilepsySignal1,46627.926.536,207
somnolenceSignal1,5214.24.03,733
drug interactionSignal1,0263.63.41,930
overdoseSignal1,3083.43.22,196
off label useSignal4,0832.62.54,151
fallSignal1,4362.42.31,184
dizziness1,6931.91.8718
drug ineffective4,2431.81.71,567
fatigue1,4741.11.04
headache1,0821.00.92
death1,0950.70.7141
nausea9670.70.6154

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.